Characterization of the SAMHD1-mediated restriction to lentiviral infection counteracted by Vpx and analyzing its role in innate immunity
Characterization of the SAMHD1-mediated restriction to lentiviral infection counteracted by Vpx and analyzing its role in innate immunity
批准号:
200802785
负责人:
Professor Dr. Thomas Gramberg
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2012
资助国家:
德国
项目状态:
已结题
起止时间:
2011-12-31 至 2016-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Non-structural proteins have emerged as key players for lentiviruses in their battle with the host immune system. Viruses of the HIV-2/SIVmac/SIVsm lineage encode, in addition to its close relative Vpr, the non-structural protein Vpx. Vpx, but not Vpr facilitates the SIV and HIV-1 infection of monocyte-derived macrophages (MDM) and dendritic cells (DC), where it has been proposed to neutralize an unknown restriction factor. Recently, SAMHD1 has been identified as the putative restriction factor and linked to the Vpx phenotype. The mechanism of the myeloid restriction is not clear but the importance of the phosphohydrolase domain suggests that its putative nuclease activity might be key. Since SAMHD1 is expressed in divergent cell lines, it is most likely not determining the myeloid cell specificity of the block. This project will use gene transfer and proteomics approaches to identify potential myeloid cell specific cofactors of SAMHD1. We will also characterize the mechanism of the SAMHD1 block and analyze the binding of Vpx to SAMHD1. It has been reported that overcoming this block by Vpx triggers an innate immune response to HIV-1 in DC. We will determine whether this effect is unique to DC or whether it is also present in MDM, which are main target cells of HIV-1 in vivo. Understanding this immune response and the role of Vpx in infection might answer the question why HIV-1 encodes only Vpr and not Vpx. The Vpx-SAMHD1 interaction will also provide clues to Vpr, which most likely functions through a similar pathway. The insights on the role of Vpx and Vpr in innate immunity may unearth a vulnerable step in infection that could be targeted by antiviral drug development.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Analysis of the TRIM5α-mediated restriction of retrotransposons
-
批准号:416905780
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Professor Dr. Thomas Gramberg
-
依托单位:
Intrinsic immune sensing of retroviral infections in SAMHD1 knockout mice
-
批准号:263025006
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Professor Dr. Thomas Gramberg
-
依托单位:
Physiological Role of APOBEC3
-
批准号:46938332
-
项目类别:Research Fellowships
-
资助金额:$0.0万
-
财政年份:2007
-
负责人:Professor Dr. Thomas Gramberg
-
依托单位:
国内基金
海外基金
登录
查看更多内容
基于基因编辑技术解析丹酚酸B靶向SAMHD1调控心肌线粒体RNA稳态干预心衰的分子机制研究
-
批准号:JCZRLH202601084
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
髓细胞SAMHD1相关的固有免疫记忆在心脏“高血糖记忆”中的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:于永生
-
依托单位:
SAMHD1酶介导的代谢重编程诱导阿糖胞苷耐药的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:黄晨蓉
-
依托单位:
脱氧核苷酸水解酶SAMHD1在谷氨酰胺饥饿相关代谢适应中的作用及其机制
-
批准号:LQ23H160043
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:王罕盈
-
依托单位:
马传染性贫血病毒靶向降解天然免疫限制因子SAMHD1的分子机制研究
-
批准号:--
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2022
-
负责人:任会玲
-
依托单位:
去泛素化酶USP7调控SAMHD1稳定性对结肠癌奥沙利铂化疗敏感性的影响及机制研究
-
批准号:82102740
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:刘经纬
-
依托单位:
乙肝病毒感染介导SAMHD1 O-GlcNAcylation修饰调控病毒复制的机制研究
-
批准号:82072286
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2020
-
负责人:唐霓
-
依托单位:
宿主限制因子SAMHD1对汉坦病毒复制、感染免疫的影响及调控机制
-
批准号:81971942
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:熊海蓉
-
依托单位:
SAMHD1抑制病毒及LINE-1分子机制研究
-
批准号:31970151
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2019
-
负责人:于晓方
-
依托单位:
SAMHD1肿瘤相关突变在逆转座子LINE-1异常激活中的作用机制研究
-
批准号:31900457
-
项目类别:青年科学基金项目
-
资助金额:25.0万元
-
批准年份:2019
-
负责人:高文英
-
依托单位: